Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0023890 (cirrhosis)
 42,195 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In recent years, implantation of a peritoneo-venous shunt has proven effective in the treatment of therapy-resistant ascites. From 1976 till 1983, a total of 63 shunt systems (Le Veen-, Agishi -, Denver system) were implanted in 55 patients with a mean age of 52.3 years. The most common cause for ascites was hepatic cirrhosis. The average functional period amounted to 21.7 months and the longest implantation time to nearly 7 years. The postoperative complication rate is considerable: 19 patients died in the postoperative course. The most dreaded complication is shunt infection and intravascular thrombopathy . In spite of the high complication rate, the establishment of a peritoneo-venous shunt is recommendable for combatting therapy-resistant ascites.
 ...
PMID:[Peritoneovenous shunt in the treatment of therapy resistant ascites. Results of 7 years' experience]. 672 65